Showing results (81-90 of 2,329) with videos related to

Sort By:
Pageof 233
Clinical Drug Investigation|March 29, 2008
Meta-Analyses of Cisapride, Omeprazole and Ranitidine in the Treatment of GORD: Implications for Treating Patient SubgroupsM Iskedjian, T R Einarson
Clinical Drug Investigation|March 29, 2008
Impact of a New Formulation of Low-Dose Micronised Medroxyprogesterone and 17-beta Estradiol on Lipid Profiles in Menopausal WomenR F Harrison, P Magill, S G Kilminster
Clinical Drug Investigation|March 29, 2008
Clinical experience with lamotrigine monotherapy in adults with newly diagnosed epilepsy: a review of published randomised clinical trialsE L Mullens
Clinical Drug Investigation|March 29, 2008
Pharmacokinetics and Tolerability of a New Hydroxyethyl Starch (HES) Specification [HES (130/0.4)] after Single-Dose Infusion of 6% or 10% Solutions in Healthy VolunteersJ Waitzinger, F Bepperling, G Pabst, et al.
Clinical Drug Investigation|March 29, 2008
A Phase I Determination of Azithromycin in Plasma during a 6-Week Period in Normal Volunteers after a Standard Dose of 500mg Once Daily for 3 DaysF Crokaert, A Hubloux, P Cauchie
Clinical Drug Investigation|March 29, 2008
Effects of pretreatment with dexfenfluramine and fluoxetine on metoclopramide-induced aldosterone secretion in healthy volunteersde K Sommers, J R Snyman, M van Wyk
Clinical Drug Investigation|March 29, 2008
Efficacy and tolerability comparison of ebastine 10 and 20mg with loratadine 10mg: a double-blind, randomised study in patients with perennial allergic rhinitisR J Davies,
Clinical Drug Investigation|October 10, 2009
Pharmacokinetics and antihypertensive effects of candesartan cilexetil in patients undergoing haemodialysis: an open-label, single-centre studyEgbert Godehard Schulz, Shadfar Bahri, Volker Schettler, et al.
Clinical Drug Investigation|October 10, 2009
Pancytopenia associated with levetiracetam treatmentMassimo Gallerani, Elisa Mari, Benedetta Boari, et al.
Clinical Drug Investigation|May 3, 2025
Cost-Effectiveness Analysis of Pembrolizumab Plus Chemotherapy Compared with Chemotherapy as First-Line Treatment for Advanced PD-L1-Positive Triple-Negative Breast Cancer from a Japanese Healthcare PerspectiveYugo Chisaki, Nobuhiko Nakamura, Takako Komuro, et al.
Pageof 233